Publication: BAFF, APRIL Y BAFFR: DIFFERENTIAL BIOMARKERS BETWEEN IGA VASCULITIS AND IGA NEPHROPATHY?
dc.contributor.author | Prieto-Pena, D. | |
dc.contributor.author | Genre, F. | |
dc.contributor.author | Martinez, S. Remuzgo | |
dc.contributor.author | Pulito-Cueto, V. | |
dc.contributor.author | Atienza-Mateo, B. | |
dc.contributor.author | Sevilla, B. | |
dc.contributor.author | Llorca, J. | |
dc.contributor.author | Ortego, N. | |
dc.contributor.author | Leonardo, M. | |
dc.contributor.author | Penalba, A. | |
dc.contributor.author | Martin-Penagos, L. | |
dc.contributor.author | Fillloy, J. A. Miranda | |
dc.contributor.author | Narvaez, J. | |
dc.contributor.author | Montero, L. Caminal | |
dc.contributor.author | Collado, P. | |
dc.contributor.author | Fernandez-Nebro, A. | |
dc.contributor.author | Diaz-Cordoves, G. | |
dc.contributor.author | Cigarran, S. | |
dc.contributor.author | Calvino, J. | |
dc.contributor.author | Cobelo, C. | |
dc.contributor.author | De-Argila, D. | |
dc.contributor.author | Vicente-Rabaneda, E. F. | |
dc.contributor.author | Rubio-Romero, E. | |
dc.contributor.author | Luque, M. Leon | |
dc.contributor.author | Blanco-Madrigal, J. M. | |
dc.contributor.author | Galindez-Agirregoikoa, E. | |
dc.contributor.author | Gualillo, O. | |
dc.contributor.author | Ibanez, J. Martin | |
dc.contributor.author | Castaneda, S. | |
dc.contributor.author | Blanco, R. | |
dc.contributor.author | Gonzalez-Gay, M. A. | |
dc.contributor.author | Lopez-Mejias, R. | |
dc.contributor.authoraffiliation | [Prieto-Pena, D.] Hosp Univ Marques Valdecilla, Div Rheumatol, IDIVAL, Res Grp Genet Epidemiol & Atherosclerosis Syst, Santander, Spain | |
dc.contributor.authoraffiliation | [Genre, F.] Hosp Univ Marques Valdecilla, Div Rheumatol, IDIVAL, Res Grp Genet Epidemiol & Atherosclerosis Syst, Santander, Spain | |
dc.contributor.authoraffiliation | [Martinez, S. Remuzgo] Hosp Univ Marques Valdecilla, Div Rheumatol, IDIVAL, Res Grp Genet Epidemiol & Atherosclerosis Syst, Santander, Spain | |
dc.contributor.authoraffiliation | [Pulito-Cueto, V.] Hosp Univ Marques Valdecilla, Div Rheumatol, IDIVAL, Res Grp Genet Epidemiol & Atherosclerosis Syst, Santander, Spain | |
dc.contributor.authoraffiliation | [Atienza-Mateo, B.] Hosp Univ Marques Valdecilla, Div Rheumatol, IDIVAL, Res Grp Genet Epidemiol & Atherosclerosis Syst, Santander, Spain | |
dc.contributor.authoraffiliation | [Ortego, N.] Hosp Univ Marques Valdecilla, Div Rheumatol, IDIVAL, Res Grp Genet Epidemiol & Atherosclerosis Syst, Santander, Spain | |
dc.contributor.authoraffiliation | [Blanco, R.] Hosp Univ Marques Valdecilla, Div Rheumatol, IDIVAL, Res Grp Genet Epidemiol & Atherosclerosis Syst, Santander, Spain | |
dc.contributor.authoraffiliation | [Lopez-Mejias, R.] Hosp Univ Marques Valdecilla, Div Rheumatol, IDIVAL, Res Grp Genet Epidemiol & Atherosclerosis Syst, Santander, Spain | |
dc.contributor.authoraffiliation | [Sevilla, B.] Hosp Univ San Cecilio, Div Pediat, Granada, Spain | |
dc.contributor.authoraffiliation | [Llorca, J.] Univ Cantabria, Sch Med, Dept Epidemiol & Computat Biol, Santander, Spain | |
dc.contributor.authoraffiliation | [Llorca, J.] Univ Cantabria, CIBER Epidemiol Salud Publ CIBERESP, Santander, Spain | |
dc.contributor.authoraffiliation | [Ortego, N.] Univ Granada, Dept Med, Granada, Spain | |
dc.contributor.authoraffiliation | [Leonardo, M.] Hosp Univ Marques Valdecilla, Div Pediat, Santander, Spain | |
dc.contributor.authoraffiliation | [Penalba, A.] Hosp Univ Marques Valdecilla, Div Pediat, Santander, Spain | |
dc.contributor.authoraffiliation | [Martin-Penagos, L.] Hosp Univ Marques Valdecilla, Div Nephrol, Santander, Spain | |
dc.contributor.authoraffiliation | [Fillloy, J. A. Miranda] Hosp Univ Lucus Augusti, Div Rheumatol, Lugo, Spain | |
dc.contributor.authoraffiliation | [Narvaez, J.] Hosp Univ Bellvitge, Div Rheumatol, Barcelona, Spain | |
dc.contributor.authoraffiliation | [Montero, L. Caminal] Hosp Univ Cent Asturias, Div Rheumatol, Oviedo, Spain | |
dc.contributor.authoraffiliation | [Collado, P.] Hosp Univ Severo Ochoa, Div Rheumatol, Madrid, Spain | |
dc.contributor.authoraffiliation | [Fernandez-Nebro, A.] Hosp Reg Univ Carlos Haya, Div Rheumatol, Malaga, Spain | |
dc.contributor.authoraffiliation | [Diaz-Cordoves, G.] Hosp Reg Univ Carlos Haya, Div Rheumatol, Malaga, Spain | |
dc.contributor.authoraffiliation | [Cigarran, S.] Hosp Costa Burela, Div Nephrol, Lugo, Spain | |
dc.contributor.authoraffiliation | [Calvino, J.] Hosp Univ Lucus Augusti, Div Nephrol, Lugo, Spain | |
dc.contributor.authoraffiliation | [Cobelo, C.] Hosp Univ Lucus Augusti, Div Nephrol, Lugo, Spain | |
dc.contributor.authoraffiliation | [De Argila, D.] Hosp Univ La Princesa, Dept Dermatol, Madrid, Spain | |
dc.contributor.authoraffiliation | [Vicente-Rabaneda, E. F.] Hosp Univ La Princesa, Div Rheumatol, Madrid, Spain | |
dc.contributor.authoraffiliation | [Rubio-Romero, E.] Hosp Univ Virgen Rocio, Div Rheumatol, Seville, Spain | |
dc.contributor.authoraffiliation | [Luque, M. Leon] Hosp Univ Virgen Rocio, Div Rheumatol, Seville, Spain | |
dc.contributor.authoraffiliation | [Blanco-Madrigal, J. M.] Hosp Univ Basurto, Div Rheumatol, Bilbao, Spain | |
dc.contributor.authoraffiliation | [Galindez-Agirregoikoa, E.] Hosp Univ Basurto, Div Rheumatol, Bilbao, Spain | |
dc.contributor.authoraffiliation | [Gualillo, O.] Hosp Clin Univ Santiago, SERGAS Serv Galego Saude, Santiago De Compostela, Spain | |
dc.contributor.authoraffiliation | [Gualillo, O.] IDIS Inst Invest Sanitaria Santiago, NEIRID Lab Neuroendocrine Interact Rheumatol & In, Res Lab 9, Santiago De Compostela, Spain | |
dc.contributor.authoraffiliation | [Ibanez, J. Martin] PTS Granada, CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain | |
dc.contributor.authoraffiliation | [Castaneda, S.] PTS Granada, CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain | |
dc.contributor.authoraffiliation | [Gonzalez-Gay, M. A.] Univ Cantabria, Dept Med & Psychiat, Santander, Spain | |
dc.contributor.authoraffiliation | [Gonzalez-Gay, M. A.] Hosp Univ Marques Valdecilla, Rheumatol Div, Res Grp Genet Epidemiol & Atherosclerosis Syst, IDIVAL, Santander, Spain | |
dc.contributor.authoraffiliation | [Gonzalez-Gay, M. A.] Sch Physiol, Cardiovasc Pathophysiol & Genom Res Unit, Fac Hlth Sci, Johannesburg, Spain | |
dc.contributor.funder | European Regional Development Fund (ERDF) | |
dc.contributor.funder | Fondo de Investigaciones Sanitarias from 'Instituto de Salud Carlos III' (ISCIII, Health Ministry, Spain) | |
dc.contributor.funder | Rio Hortega programme fellowship from the ISCIII | |
dc.contributor.funder | European Social Fund (ESF, 'Investing in your future') | |
dc.contributor.funder | RETICS Program - ERDF | |
dc.contributor.funder | IDIVAL | |
dc.contributor.funder | Miguel Servet type II programme fellowship from the ISCIII | |
dc.date.accessioned | 2023-05-03T13:30:06Z | |
dc.date.available | 2023-05-03T13:30:06Z | |
dc.date.issued | 2022-06-01 | |
dc.description.abstract | Background: IgA vasculitis (IgAV) and IgA nephropathy (IgAN) are inflammatory conditions [1, 2], that share pathogenic mechanisms [1], in which B-lymphocytes are described as key cells implicated in these processes. BAFF, APRIL, and BAFF-R are cytokines implicated in the development of B-lymphocytes [3, 4] and in autoimmune processes [5, 6]. In this regard, an influence of BAFF, APRIL, and BAFFR polymorphisms was observed on several immune-mediated conditions, with BAFF GCTGT>A being a shared insertion-deletion variant for inflammatory conditions [7, 8]. Objectives: To determine whether BAFF, APRIL, and BAFFR could be used as differential biomarkers between IgAV and IgAN. Methods: BAFF rs374039502 (which colocalizes with BAFF GCTGT>A), two tag variants within APRIL (rs11552708 and rs6608), and two tag variants within BAFFR (rs7290134 and rs77874543) were genotyped in 394 Caucasian IgAV patients, 95 patients with IgAN, and 832 matched healthy controls. | |
dc.description.sponsorship | This study was supported by the European Regional Development Fund (ERDF) and “Fondo de Investigaciones Sanitarias” (grant PI18/00042 and PI21/00042) from ‘Instituto de Salud Carlos III’ (ISCIII, Health Ministry, Spain). DP-P is a recipient of a Río Hortega programme fellowship from the ISCIII, co-funded by the European Social Fund (ESF, 'Investing in your future') [grant number CM20/00006]; SR-M is supported by funds of the RETICS Program co-funded by ERDF [grant number RD16/0012/0009]; VP-C is supported by a pre-doctoral grant from IDIVAL [grant number PREVAL 18/01]; RL-M is a recipient of a Miguel Servet type II programme fellowship from the ISCIII, co-funded by ESF 'Investing in your future' [grant number CPII21/00004]. | |
dc.description.version | No | |
dc.identifier.citation | Prieto-Peña, D., Genre, F., Martinez, S. R., Pulito-Cueto, V., Atienza-Mateo, B., Sevilla, B., et al. AB0146 BAFF, APRIL y BAFFR: DIFFERENTIAL BIOMARKERS BETWEEN IGA VASCULITIS AND IGA NEPHROPATHY? Annals Of The Rheumatic Diseases, 81(Suppl 1), 1203-1204. https://doi.org/10.1136/annrheumdis-2022-eular.425 | |
dc.identifier.doi | 10.1136/annrheumdis-2022-eular.425 | |
dc.identifier.essn | 1468-2060 | |
dc.identifier.issn | 0003-4967 | |
dc.identifier.unpaywallURL | https://ard.bmj.com/content/annrheumdis/81/Suppl_1/1203.full.pdf | |
dc.identifier.uri | http://hdl.handle.net/10668/20051 | |
dc.identifier.wosID | 850279005004 | |
dc.issue.number | 1 | |
dc.journal.title | Annals of the rheumatic diseases | |
dc.journal.titleabbreviation | Ann. rheum. dis. | |
dc.language.iso | en | |
dc.organization | Hospital Universitario San Cecilio | |
dc.organization | Hospital Universitario Regional de Málaga | |
dc.organization | Hospital Universitario Virgen del Rocío | |
dc.page.number | 1203-1204 | |
dc.provenance | Realizada la curación de contenido 12/03/2025 | |
dc.publisher | BMJ Group | |
dc.relation.projectID | PI18/00042 | |
dc.relation.projectID | PI21/00042 | |
dc.relation.projectID | CM20/00006 | |
dc.relation.projectID | RD16/0012/0009 | |
dc.relation.projectID | CPII21/00004 | |
dc.relation.publisherversion | https://ard.bmj.com/content/81/Suppl_1/1203 | |
dc.rights.accessRights | Restricted Access | |
dc.subject | B-Lymphocytes | |
dc.subject | Cells | |
dc.subject | Glomerulonephritis, IGA | |
dc.subject | Cytokines | |
dc.subject.decs | Linfocitos B | |
dc.subject.decs | Glomerulonefritis por IGA | |
dc.subject.decs | Vasculitis por IgA | |
dc.subject.decs | Biomarcadores | |
dc.subject.decs | Citocinas | |
dc.subject.mesh | Glomerulonephritis, IGA | |
dc.subject.mesh | IgA Vasculitis | |
dc.subject.mesh | Cytokines | |
dc.subject.mesh | White People | |
dc.title | BAFF, APRIL Y BAFFR: DIFFERENTIAL BIOMARKERS BETWEEN IGA VASCULITIS AND IGA NEPHROPATHY? | |
dc.type | conference output | |
dc.type.hasVersion | VoR | |
dc.volume.number | 81 | |
dc.wostype | Meeting Abstract | |
dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- RISalud_Accesorestringido.pdf
- Size:
- 93.39 KB
- Format:
- Adobe Portable Document Format